TANDEM DIABETES CARE INC (TNDM) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8753722037
TANDEM DIABETES CARE INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.01 bn USD |
| Gross profit | 546.01 m USD |
| Operating income | -187.26 m USD |
| EBIT | -192.37 m USD |
| Net income | -204.71 m USD |
| Diluted EPS – continuing operations | -3.04 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TANDEM DIABETES CARE INC
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
More stocks
- Tong Hsing Electronic Industries Ltd (6271.TW)
- Lotus Pharmaceutical Co Ltd (1795.TW)
- Ruffer Investment Company Ltd (RICA.L)
- Norion Bank AB (NORION.ST)
- Zhejiang Jolly Pharmaceutical Co Ltd (300181.SZ)
- Liaoning Chengda Biotechnology Co. Ltd. A (688739.SS)
- Minera Valparaiso S.A. (MINERA.SN)
- Alimak Group AB (publ) (ALIG.ST)
- Oddity Tech Ltd (ODD)
- Navigo Invest AB (publ) (NAVIGO PREF.ST)
- CPT Technology Group Co Ltd (000536.SZ)
- Alma Media Oyj (ALMA.HE)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.